AJMC - Change is Coming

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|December 1, 2007

Supplements and Featured Publications

An Integrated Approach: Bisphosphonate Management for the Treatment of Osteoporosis
Volume 13
Issue 11 Suppl

CME/CE Posttest

Download PDF: CME/CE Posttest

Articles in this issue

about 18 years ago

Article

about 18 years ago

Article

Participating Faculty

about 18 years ago

Article

An Integrated Approach: Bisphosphonate Management for the Treatment of Osteoporosis

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC letter from the editor

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

AJMC original research policy

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

AJMC trends from the field

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

AJMC original research policy

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

AJMC research letter

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

New Dermatologic Therapies Make Waves at Maui Derm 2026

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.